Article
Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine.
Journal of clinical pharmacy and therapeutics - 1 Apr 2012
Wan Rosalina W R, Teh L K, Mohamad N, Nasir A, Yusoff R, Baba A A, Salleh M Z
Abstract excerpt
WHAT IS KNOWN AND OBJECTIVE: Genetic polymorphisms of thiopurine S-methyltransferase (TPMT) and inosine triphosphate pyrophosphohydrolase (ITPA 94C>A) contribute to variable responses, including fatal adverse effects, among subjects treated with 6-mercaptopurine (6-MP). Our objectives were to investigate the distribution of specific TPMT and ITPA genotypes in healthy subjects and patients with acute lymphoblastic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
